An unremitting trend of lower spending by large pharmaceutical customers in North America hurt Waters’ sales in the second quarter, but strong sales in Asia pushed the firm’s overall revenues up 6 percent year over year to $302 million, the company said this week.
A depressed pharmaceutical spending market has been a common refrain from Waters officials over the past five quarters, but while they believe the decline has bottomed out they are maintaining a conservative outlook.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.